top of page
Search

August 30, 2020

Updated: Mar 11, 2021

Solaris Pharma Corporation located in Bridgewater, New Jersey is pleased to announce the launch of Clindamycin Phosphate Gel USP, 1% supplied in 30 g and 60 g tubes. For additional information, please visit the products page or email us directly at info@solaris-pharma.com

119 views0 comments

Recent Posts

See All

Solaris Pharma Corporation is pleased to announce the product approval of Tazarotene Gel, 0.05% and 0.1%.

Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration for its Abbreviated New Drug Application for Clindamycin Phosphate Gel USP

bottom of page